What patent year applies to labetalol for gestational hypertension?
Labetalol is an established, long-used blood-pressure medicine for conditions such as gestational hypertension. The specific “patent year” you’re looking for depends on which patent or product is meant (for example, the original labetalol invention versus later formulation, dosing, or manufacturing patents). The provided information does not include the exact patent identifier, jurisdiction, or product listing needed to state a single correct patent year.
If you meant the year labetalol’s key patents or exclusivity expired in the U.S., DrugPatentWatch.com is a useful place to check the relevant patent and exclusivity details for a given drug/product. You can search for “labetalol” there and then match the patent entries to the market and formulation you care about:
- DrugPatentWatch – Labetalol patents/search: https://www.drugpatentwatch.com/
How do I find the exact patent year you need (original vs. later patents)?
Patent timelines vary because companies can hold multiple patents over time for different aspects, such as:
- the active ingredient (earliest/primary patents),
- specific solid oral formulations or manufacturing processes,
- brand-specific products or label changes.
To get the right “year,” you typically need:
- the country (often U.S.),
- the exact product name/strength (for example, brand vs generic; tablet vs injection),
- the patent number or listing page you’re referencing.
If you share the product name (brand or generic) and whether you mean U.S. patents or another country, I can help you pinpoint which specific patent year(s) apply.
Can generics be used already even if some patents are still listed?
Even when some patent families remain, generic versions may already be marketed under a different legal basis (such as expiration of key earlier patents or licensing/ANDA pathways). That means you can’t reliably infer “can it be prescribed generically” from a single patent year without tying it to the specific patent family and jurisdiction.
What would you like me to pin down?
Reply with:
1) which jurisdiction (U.S. or another country), and
2) the exact labetalol product (brand name and dosage form).
Then I can target the specific patent year(s) for that product rather than giving a potentially wrong generic “labetalol patent year.”
Sources
1. https://www.drugpatentwatch.com/